EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
4.2.3.97 | (2E,6E)-farnesyl diphosphate |
- |
Streptomyces clavuligerus |
(-)-delta-cadinene + diphosphate |
- |
? |
4.2.3.97 | (2E,6E)-farnesyl diphosphate |
cyclization mechanism involves the intermediacy of nerolidyl diphosphate leading to a helminthogermacradienyl cation. Following a 1,3-hydride shift of the original H-1si of farnesyl diphosphate, cyclization and deprotonation will give (-)-delta-cadinene |
Streptomyces clavuligerus |
(-)-delta-cadinene + diphosphate |
more than 95% of product |
? |
4.2.3.97 | (2E,6E)-farnesyl diphosphate |
- |
Streptomyces clavuligerus ATCC 27064 |
(-)-delta-cadinene + diphosphate |
- |
? |
4.2.3.97 | (2E,6E)-farnesyl diphosphate |
cyclization mechanism involves the intermediacy of nerolidyl diphosphate leading to a helminthogermacradienyl cation. Following a 1,3-hydride shift of the original H-1si of farnesyl diphosphate, cyclization and deprotonation will give (-)-delta-cadinene |
Streptomyces clavuligerus ATCC 27064 |
(-)-delta-cadinene + diphosphate |
more than 95% of product |
? |